Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico
- PMID: 20003692
Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico
Abstract
Objectives: To analyse the proportion of multidrug-resistant tuberculosis (MDR-TB) in cultures performed during the period 2000-2002 in Los Altos, Selva and Norte regions, Chiapas, Mexico, and to analyse MDR-TB in terms of clinical and sociodemographic indicators.
Methods: Cross-sectional study of patients with pulmonary tuberculosis (PTB) from the above regions. Drug susceptibility testing results from two research projects were analysed, as were those of routine sputum samples sent in by health personnel for processing (n = 114). MDR-TB was analysed in terms of the various variables of interest using bivariate tests of association and logistic regression.
Results: The proportion of primary MDR-TB was 4.6% (2 of 43), that of secondary MDR-TB was 29.2% (7/24), while among those whose history of treatment was unknown the proportion was 14.3% (3/21). According to the logistic regression model, the variables most highly associated with MDR-TB were as follows: having received anti-tuberculosis treatment previously, cough of >3 years' duration and not being indigenous.
Conclusions: The high proportion of MDR cases found in the regions studied shows that it is necessary to significantly improve the control and surveillance of PTB.
Similar articles
-
Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):570-4. Southeast Asian J Trop Med Public Health. 2002. PMID: 12693593
-
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13. Int J Infect Dis. 2009. PMID: 19285897
-
Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.Ethiop Med J. 2008 Oct;46(4):367-74. Ethiop Med J. 2008. PMID: 19271401
-
[Tuberculosis in Switzerland].Ther Umsch. 2011 Jul;68(7):365-8. doi: 10.1024/0040-5930/a000178. Ther Umsch. 2011. PMID: 21728153 Review. German.
-
Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis.PLoS One. 2022 Jun 16;17(6):e0270003. doi: 10.1371/journal.pone.0270003. eCollection 2022. PLoS One. 2022. PMID: 35709161 Free PMC article.
Cited by
-
Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China.PLoS One. 2014 Feb 5;9(2):e88330. doi: 10.1371/journal.pone.0088330. eCollection 2014. PLoS One. 2014. PMID: 24505476 Free PMC article.
-
Tuberculosis treatment failure: what are the risk factors? A comprehensive literature review.Multidiscip Respir Med. 2025 Jul 4;20(1):1030. doi: 10.5826/mrm.2025.1030. Multidiscip Respir Med. 2025. PMID: 40622307 Free PMC article.
-
Sociodemographic factors associated with the success or failure of anti-tuberculosis treatment in the Chiapas Highlands, Mexico, 2019-2022.PLoS One. 2024 Jan 26;19(1):e0296924. doi: 10.1371/journal.pone.0296924. eCollection 2024. PLoS One. 2024. PMID: 38277365 Free PMC article.
-
A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border.Mem Inst Oswaldo Cruz. 2013 Apr;108(2):160-6. doi: 10.1590/0074-0276108022013006. Mem Inst Oswaldo Cruz. 2013. PMID: 23579794 Free PMC article.
-
Magnetic Nanoparticle-Based Biosensing Assay Quantitatively Enhances Acid-Fast Bacilli Count in Paucibacillary Pulmonary Tuberculosis.Biosensors (Basel). 2018 Dec 12;8(4):128. doi: 10.3390/bios8040128. Biosensors (Basel). 2018. PMID: 30545099 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources